Over the past few days, pivotal developments—spanning technical innovation, policy changes, and corporate strategy—reveal a sector at an inflection point. Here’s what the latest trends mean ...

Andy Grove, formerly the CEO of Intel back in the day when it knew how to make chips, was one of my favorite corporate ...

"In terms of the inflection point for the market, you know, both Novo Nordisk (NVO) and Eli Lilly (LLY) have clinical catalysts that are scheduled throughout the year. But really, I think what is ...